SWK Holdings Provides Portfolio Update Highlighting Recent Achievements

▤ Summary

SWK Holdings issued a portfolio update highlighting progress across its life sciences investments and royalty holdings. The company described recent royalty acquisitions, milestone payments, facility expansion work, and management hires at portfolio company Enteris BioPharma. It also summarized recent commercial and regulatory developments at several healthcare and biotech partners, including Aimmune, Emergent, Biolase, DxTerity, Eton, Harrow Health, and Misonix. The update emphasized SWK's financing strategy and the growth potential of its partner companies.

▦ Linked Companies